EMA Priority Medicines scheme (PRIME): will more paying-for-performance agreements be needed due to immature data?

F. Antoñanzas (), C. A. Juárez-Castelló and R. Rodríguez-Ibeas
Additional contact information
F. Antoñanzas: University of La Rioja
C. A. Juárez-Castelló: University of La Rioja
R. Rodríguez-Ibeas: University of La Rioja

The European Journal of Health Economics, 2018, vol. 19, issue 7, No 1, 905-907

Date: 2018
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
http://link.springer.com/10.1007/s10198-017-0944-0 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:eujhec:v:19:y:2018:i:7:d:10.1007_s10198-017-0944-0

Ordering information: This journal article can be ordered from
http://www.springer. ... cs/journal/10198/PS2

DOI: 10.1007/s10198-017-0944-0

Access Statistics for this article

The European Journal of Health Economics is currently edited by J.-M.G.v.d. Schulenburg

More articles in The European Journal of Health Economics from Springer, Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ) Contact information at EDIRC.
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().